122350-63-4

Upstream product

• 122350-55-4 N-9-fluorenylmethyloxycarbonyl-1 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl> glutamic acid benzyl ester 
• 61243-32-1 Phe-Phe-Gly-Leu-Met-OMe 
• 122350-56-5 N-9-fluorenylmethyloxycarbonyl-1 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl> glutamyl, phenylalanyl, phenylalanyl, glycine methyl ester 
• 72217-96-0 H-Leu-Met-OCH₃ 
• 41355-50-4 2,3,4,6-tetra-O-acetyl-D-glucosyl-1-amine 
• 122350-53-2 (S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-{(S)-1-[(S)-1-(methoxycarbonylmethyl-carbamoyl)-2-phenyl-ethylcarbamoyl]-2-phenyl-ethylcarbamoyl}-butyric acid 
• 122350-52-1 (4S)-5-benzyloxy-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxopentanoic acid 

Relevant academic research and scientific papers

THE INCORPORATION OF SUGAR MOIETIES TO NEUROPEPTIDES; COMPARATIVE STUDY OF DIFFERENT METHODS

By using both β-N-glycosylation and β-O-glycosylation procedures, different methods for the incorporation of glucose moieties to proline, hydroxyproline or glutamic acid containing protected neuropeptides have been examined.As far as glycosylation of Glu